Accessibility Menu
Protect Pharmaceutical logo

Protect Pharmaceutical(OTC) PRTT

Market Cap$17.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
$0.30
-14.29%
-0.05Today

Protect Pharmaceutical Financials at a Glance

Market Cap

$17.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$81.73M

Net Income (TTM)

$23.25M

EPS (TTM)

$0.86

P/E Ratio

0.35

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$0.30

Volume

30,716

Open

$0.31

Previous Close

$0.30

Daily Range

$0.30 - $0.33

52-Week Range

$0.02 - $0.70

Estimated Earnings Date

Jul 8, 2024

PRTT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Protect Pharmaceutical

Protect Pharmaceutical Corporation is a company focused on crop farming and agricultural businesses. It operates the Can Noguera property in Spain, which encompasses extensive arable land and resources.

Products and Services
  • Crop farming and agricultural production
  • Management of arable land and natural resources
  • Acquisition and development of agricultural properties
Growth Outlook
  • Recent quarterly revenue reached $26.3 million, indicating strong market demand
  • Net income for the last quarter was $6.6 million, showcasing profitability
  • Significant cash reserves of $20 million support future expansion
Financial Highlights
  • Trailing twelve months (TTM) revenue of $97.5 million reflects consistent growth
  • Current ratio of 3.37 indicates strong liquidity position
  • Net profit margin of 25.2% demonstrates effective cost management
Protect Pharmaceutical Corporation has established itself as a key player in the agricultural sector, leveraging its strategic property holdings to drive growth. The company's recent financial performance highlights its ability to generate substantial revenue and maintain profitability, making it an attractive option for potential investors. With a solid cash position and a focus on expanding its agricultural operations, Protect Pharmaceutical Corporation is well-positioned for future success.
AI Generated • Jul 17, 2026

Industry

Pharmaceuticals

CEO

Boris Stepanov

Headquarters

Las Vegas, NV 89115, US

PRTT Financials

Key Financial Metrics (TTM)

Gross Margin

55.70%

Operating Margin

33.55%

Net Income Margin

25.17%

Return on Equity

1.93%

Return on Capital

-0.00%

Return on Assets

1.57%

Earnings Yield

2.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

57.45M

Volume

30.72K

Avg. Volume

20.20K

Financials (TTM)

Gross Profit

$45.08M

Operating Income

$27.84M

EBITDA

$27.84M

Operating Cash Flow

$6.18M

Capital Expenditure

-$3.49M

Free Cash Flow

$2.69M

Cash & ST Invst.

$75.76M

Total Debt

$4.41M

Protect Pharmaceutical Performance Analysis

Protect Pharmaceutical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 81,799,0003.8%
20232023-12-31USD 136,158,00066.5%
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Protect Pharmaceutical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-3.0%
Q12025-03-31-13.7%
Q22025-06-302.6%
Q12026-03-31N/A
Protect Pharmaceutical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.4318.4%
20232023-12-31USD 0.8088.0%
20242024-12-31USD 0.9822.7%
20252025-12-31USD -5.79N/A
Protect Pharmaceutical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-60.0%
Q12025-03-31-38.9%
Q22025-06-309.1%
Q12026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$17.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$28.73K

N/A

Employees

600

N/A

Net Income

-$1.50K

-100.0%

EBITDA

-$1.50K

-100.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$75.76M

+20.2%

Total Debt

$4.41M

+14.1%

Accounts Receivable

$60.64M

-12.7%

Inventory

$124.77M

+50.3%

Long Term Debt

$0.00

N/A

Short Term Debt

$4.41M

+14.1%

Return on Assets

1.57%

N/A

Return on Invested Capital

2.55%

N/A

Free Cash Flow

-$4.57M

-276.9%

Operating Cash Flow

-$2.10M

-181.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ETCCEnvironmental Tectonics Corporation
$1.79+11.18%
CRWECrown Equity Holdings Inc.
$0.86+0.00%
CVVIFSociedad Comercial del Plata S.A.
$0.00-98.79%
QUTIFQuestor Technology Inc.
$0.28+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$108.27-0.14%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.29+0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$72.84-0.03%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$27.63+0.00%

Questions About PRTT

What is the current price of Protect Pharmaceutical?

Protect Pharmaceutical is trading at $0.30 per share.

What is the 52-week range for Protect Pharmaceutical?

Over the past 52 weeks, Protect Pharmaceutical has traded between $0.02 and $0.70.

How much debt does Protect Pharmaceutical have?

As of the most recent reporting period, Protect Pharmaceutical reported total debt of $4.50K.

How much cash does Protect Pharmaceutical have on hand?

Protect Pharmaceutical reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Protect Pharmaceutical’s dividend yield?

Protect Pharmaceutical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.